Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Ki-1+ Anaplastic Large Cell Lymphoma
0.080 AlteredExpression disease BEFREE In this review, we focus on the impact of deregulated expression of AP-1 TFs in CD30-positive lymphomas including Classical Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma. 29597249 2018
Ki-1+ Anaplastic Large Cell Lymphoma
0.080 Biomarker disease BEFREE The AP-1 factor basic leucine zipper transcription factor, ATF-like 3 (BATF3), is highly transcribed in cHL and ALCL; however, its functional importance in lymphomagenesis is unknown. 28659618 2018
Ki-1+ Anaplastic Large Cell Lymphoma
0.080 Biomarker disease BEFREE Both BATFs bind classical AP-1 motifs and interact with in ALCL deregulated AP-1 factors. 29588546 2018
Ki-1+ Anaplastic Large Cell Lymphoma
0.080 AlteredExpression disease BEFREE Deregulated expression of AP-1 transcription factors is implicated in the pathogenesis of various lymphomas such as classical Hodgkin lymphomas, anaplastic large cell lymphomas, diffuse large B cell lymphomas and adult T cell leukemia/lymphoma. 27600282 2017
Ki-1+ Anaplastic Large Cell Lymphoma
0.080 AlteredExpression disease BEFREE Constitutive control of AKT1 gene expression by JUNB/CJUN in ALK+ anaplastic large-cell lymphoma: a novel crosstalk mechanism. 25987255 2015
Ki-1+ Anaplastic Large Cell Lymphoma
0.080 Biomarker disease BEFREE Here, we discuss the role of AP-1 in the pathogenesis of ALCL and provide an overview of pathological epigenetic changes in ALCL cells. 25961698 2015
Ki-1+ Anaplastic Large Cell Lymphoma
0.080 AlteredExpression disease BEFREE It has been shown that ALK-NPM fusion upregulates platelet-derived growth factor receptor beta (PDGFRB) via JUN and transcription factor Jun B (JUNB) in ALCL. 24750504 2014
Ki-1+ Anaplastic Large Cell Lymphoma
0.080 Biomarker disease BEFREE Together, our data identify PDGFRB as a previously unknown JUN and JUNB target that could be a highly effective therapy for ALCL. 23064464 2012